Clinical Trials Directory

Trials / Completed

CompletedNCT04501068

Evaluation of the Ambu® AuraGain in Ambulatory Surgery

Analysis of 150 Consecutive Uses of the Ambu® AuraGain Supraglottic Airway by One Anaesthetist in Ambulatory Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Hospital General Universitario Gregorio Marañon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study was designed to evaluate the success rate, time of insertion, sealing efficacy and security of the Ambu® AuraGain in patients undergoing ambulatory surgery by one anesthetist

Detailed description

Supraglottic devices (SGD), in all their different forms, have become an authentic innovation in airway management especially in day surgery. The Ambu® AuraGainTM (Ambu A/S, Ballerup, Denmark) is a new single-use, anatomically curved supraglottic airway with an integrated gastric access port designed to provide functional separation of the respiratory and digestive tracts allowing the exit of gastric contents and the passage of a gastric tube to manage gastric contents. Its characteristics in the design, composition by a smooth and atraumatic material, the presence of the gastric drainage access, with potential improved patient safety and its characteristic of being disposable, suggests a significant expansion of its use in the coming years. The series in the literature reporting performance or safety of use of the Ambu® AuraGainTM come from studies on selected cases and in certain surgical procedures. However, there are limited studies that have evaluated the efficacy of the device in routine clinical practice in patients intervened in ambulatory surgery and performed by a single investigator.

Conditions

Interventions

TypeNameDescription
DEVICEAmbu® AuraGainTMEvaluate the time of insertion, performance, security and insertion success rate of the Ambu® AuraGainTM in patients undergoing ambulatory surgery and general anaesthesia

Timeline

Start date
2018-01-01
Primary completion
2020-06-01
Completion
2020-06-01
First posted
2020-08-06
Last updated
2020-08-06

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04501068. Inclusion in this directory is not an endorsement.